Compounds > cytarabine

cytarabine and framycetin

cytarabine has been researched along with framycetin in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (50.00)18.2507
2000's1 (16.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Lefebvre, PP; Malgrange, B; Moonen, G; Staecker, H; Van de Water, TR1
Bhalla, K; Bullock, G; Huang, Y; Ibrado, AM; Nuñez, G; Ray, S; Tang, C1
Acquaviva, AM; Apicella, A; Di Popolo, A; Memoli, A; Pignata, S; Ricchi, P; Salzano, S; Zarrilli, R1

Other Studies

6 other study(ies) available for cytarabine and framycetin

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
Retinoic acid stimulates regeneration of mammalian auditory hair cells.
    Science (New York, N.Y.), 1993, Apr-30, Volume: 260, Issue:5108

    Topics: Animals; Cytarabine; Hair Cells, Auditory; Microscopy, Electron; Neomycin; Organ Culture Techniques; Organ of Corti; Rats; Regeneration; Tretinoin

1993
Enforced expression of Bcl-XS induces differentiation and sensitizes chronic myelogenous leukemia-blast crisis K562 cells to 1-beta-D-arabinofuranosylcytosine-mediated differentiation and apoptosis.
    Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research, 1996, Volume: 7, Issue:12

    Topics: Antimetabolites, Antineoplastic; Apoptosis; bcl-2-Associated X Protein; bcl-X Protein; Blotting, Northern; Blotting, Western; Cell Differentiation; Cytarabine; Dose-Response Relationship, Drug; Erythroid Precursor Cells; Gene Expression Regulation, Neoplastic; HL-60 Cells; Humans; Leukemia, Myeloid; Neomycin; Plasmids; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Transfection

1996
Cell cycle block at G1-S or G2-M phase correlates with differentiation of Caco-2 cells: effect of constitutive insulin-like growth factor II expression.
    Gastroenterology, 1999, Volume: 116, Issue:6

    Topics: Anti-Bacterial Agents; Caco-2 Cells; Cell Cycle; Cell Differentiation; Cell Division; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cytarabine; Drug Resistance, Microbial; G1 Phase; G2 Phase; Humans; Insulin-Like Growth Factor II; Intestinal Mucosa; Neomycin; Nocodazole; Ploidies; Retinoblastoma Protein; Transfection

1999